Waiver Of Intellectual Property Protections For COVID-19 Vaccine Unlikely To Have Meaningful Impact In Short Term (JSON)

lexblog.com/lib/Q8GJ0FDQview recordjson

{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Waiver Of Intellectual Property Protections For COVID-19 Vaccine Unlikely To Have Meaningful Impact In Short Term",
    "url": "https://www.lexblog.com/2021/05/10/ip-protections-covid-19-vaccine/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-Q8GJ0FDQ",
        "url": "https://www.lexblog.com/lib/Q8GJ0FDQ/"
    },
    "datePublished": "2021-05-10T18:29:52-04:00",
    "dateModified": "2022-08-11T09:54:01-04:00",
    "author": {
        "@type": "Person",
        "name": "Lorna Tanner, Thomas Carr*"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Sheppard, Mullin, Richter & Hampton LLP"
    },
    "organizationScope": "at-publication",
    "about": "Intellectual Property",
    "sourceUrl": "https://www.fdalawblog.com/?p=1783",
    "sourceStability": "may-move"
}